Illumina, Inc. (0J8Z.L)

USD 73.11

(4.55%)

Long Term Debt Summary of Illumina, Inc.

  • Illumina, Inc.'s latest annual long term debt in 2023 was 1.48 Billion USD , down -33.26% from previous year.
  • Illumina, Inc.'s latest quarterly long term debt in 2024 Q1 was 1.49 Billion USD , up 0.07% from previous quarter.
  • Illumina, Inc. reported annual long term debt of 2.23 Billion USD in 2022, down -9.64% from previous year.
  • Illumina, Inc. reported annual long term debt of 2.46 Billion USD in 2021, up 83.71% from previous year.
  • Illumina, Inc. reported quarterly long term debt of 2.6 Billion USD for 2024 Q3, up 33.42% from previous quarter.
  • Illumina, Inc. reported quarterly long term debt of 1.49 Billion USD for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Illumina, Inc. (2023 - 1999)

Created with Highcharts 11.1.0YearsLong Term Debt2000200220042006200820102012201420162018202020220 USD500000000 USD1000000000 USD1500000000 USD2000000000 USD2500000000 USD3000000000 USD

Historical Annual Long Term Debt of Illumina, Inc. (2023 - 1999)

Year Long Term Debt Long Term Debt Growth
2023 1.48 Billion USD -33.26%
2022 2.23 Billion USD -9.64%
2021 2.46 Billion USD 83.71%
2020 1.34 Billion USD -26.8%
2019 1.83 Billion USD 106.29%
2018 890 Million USD -24.7%
2017 1.18 Billion USD 12.81%
2016 1.04 Billion USD 3.17%
2015 1.01 Billion USD 2.93%
2014 986.78 Million USD 17.57%
2013 839.3 Million USD 4.21%
2012 805.4 Million USD -0.24%
2011 807.36 Million USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD -100.0%
2007 400 Million USD 0.0%
2006 - USD -100.0%
2005 54 Thousand USD 0.0%
2004 - USD -100.0%
2003 24.99 Million USD -2.42%
2002 25.62 Million USD 4242.37%
2001 590 Thousand USD -33.46%
2000 886.62 Thousand USD 0.0%
1999 - USD 0.0%

Peer Long Term Debt Comparison of Illumina, Inc.

Name Long Term Debt Long Term Debt Difference
uniQure N.V. 130.06 Million USD -1044.812%
Agios Pharmaceuticals, Inc. 56.98 Million USD -2512.831%
Amicus Therapeutics, Inc. 387.85 Million USD -283.903%
Atara Biotherapeutics, Inc. 45.69 Million USD -3158.705%
bluebird bio, Inc. 224.41 Million USD -563.491%
Cara Therapeutics, Inc. 37.07 Million USD -3915.75%
Imunon, Inc. 1.13 Million USD -130595.089%
Editas Medicine, Inc. 24.37 Million USD -6009.47%
IQVIA Holdings Inc. 12.95 Billion USD 88.506%
Mettler-Toledo International Inc. 1.97 Billion USD 24.629%
Myriad Genetics, Inc. 130.9 Million USD -1037.51%
Neurocrine Biosciences, Inc. 258.3 Million USD -476.461%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -4385.48%
Verastem, Inc. 40.08 Million USD -3614.514%
Walgreens Boots Alliance, Inc. 8.04 Billion USD 81.489%
Waters Corporation 2.3 Billion USD 35.416%
Thermo Fisher Scientific Inc. 31.3 Billion USD 95.244%
Biogen Inc. 7.18 Billion USD 79.285%
Nektar Therapeutics 112.62 Million USD -1222.087%
Perrigo Company plc 3.63 Billion USD 59.012%
Dynavax Technologies Corporation 252.41 Million USD -489.895%
Corbus Pharmaceuticals Holdings, Inc. 3.23 Million USD -45876.216%
Iovance Biotherapeutics, Inc. 1 Million USD -148800.0%
Heron Therapeutics, Inc. 173.75 Million USD -756.964%
Unity Biotechnology, Inc. 23.53 Million USD -6225.672%
BioMarin Pharmaceutical Inc. 593.09 Million USD -151.056%
Sangamo Therapeutics, Inc. 33.51 Million USD -4342.787%
Evolus, Inc. 120.35 Million USD -1137.132%
Adicet Bio, Inc. 17.7 Million USD -8311.004%
Aclaris Therapeutics, Inc. 3.07 Million USD -48338.517%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 44.911%
Esperion Therapeutics, Inc. 501.54 Million USD -196.882%
FibroGen, Inc. 89.69 Million USD -1560.033%
Agilent Technologies, Inc. 2.73 Billion USD 45.558%
OPKO Health, Inc. 222.03 Million USD -570.618%
Homology Medicines, Inc. 43.17 Million USD -3348.675%
Geron Corporation 35.05 Million USD -4148.096%
Alnylam Pharmaceuticals, Inc. 2.34 Billion USD 36.45%
Exelixis, Inc. 189.94 Million USD -683.915%
Viking Therapeutics, Inc. 936 Thousand USD -158981.197%
Anavex Life Sciences Corp. - USD -Infinity%
Intellia Therapeutics, Inc. 96.74 Million USD -1439.066%
Zoetis Inc. 6.56 Billion USD 77.316%
Axsome Therapeutics, Inc. 178.07 Million USD -736.188%
Abeona Therapeutics Inc. 4.4 Million USD -33725.534%
Vertex Pharmaceuticals Incorporated 724.7 Million USD -105.464%
Kala Pharmaceuticals, Inc. 34.19 Million USD -4255.075%
Ionis Pharmaceuticals, Inc. 1.4 Billion USD -6.329%
Sarepta Therapeutics, Inc. 1.13 Billion USD -31.477%
Corcept Therapeutics Incorporated - USD -Infinity%
Halozyme Therapeutics, Inc. 1.49 Billion USD 0.684%
Blueprint Medicines Corporation 610.96 Million USD -143.714%
Insmed Incorporated 1.19 Billion USD -24.775%
TG Therapeutics, Inc. 100.11 Million USD -1387.245%
Incyte Corporation 29.16 Million USD -5005.96%
Emergent BioSolutions Inc. 446.5 Million USD -233.483%